Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Carcinoma and IRF2[original query] |
---|
STAT3 polymorphism can predict the response to interferon-a therapy in patients with metastatic renal cell carcinoma. European urology 2013 Apr 63 (4): 745-52. Eto Masatoshi, Kamba Tomomi, Miyake Hideaki, Fujisawa Masato, Kamai Takao, Uemura Hirotsugu, Tsukamoto Taiji, Azuma Haruhito, Matsubara Akio, Nishimura Kazuo, Nakamura Tsuyoshi, Ogawa Osamu, Naito Seiji, |
Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma. BMC cancer 2019 8 19 (1): 789. Huang Fung-Yu, Wong Danny Ka-Ho, Tsui Vivien Wai-Man, Seto Wai-Kay, Mak Lung-Yi, Cheung Tan-To, Lai Keane K-Y, Yuen Man-Fu |
Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma. Cancer genetics 2023 7 276-277 30-35. Mei Ling Chong, James Knight, Gang Peng, Weizhen Ji, Hongyan Chai, Yufei Lu, Shengming Wu, Peining Li, Qiping |
Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. Global medical genetics 2024 4 11 (2): 150-158. Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zha |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: